Search research articles
Contact Us
Filters
Showing results (11-20 of 29) with videos related to
Page
of 3
Sort By:
Pharmacoeconomics
|
February 8, 2000
Cost-effectiveness analysis of enoxaparin versus unfractionated heparin for acute coronary syndromes. A Canadian hospital perspective
R M Balen, C A Marra, P J Zed, et al.
Pharmacoeconomics
|
January 11, 2001
Cost analysis of an adult outpatient parenteral antibiotic therapy (OPAT) programme. A Canadian teaching hospital and Ministry of Health perspective
A O Wai, L Frighetto, C A Marra, et al.
The Annals of Pharmacotherapy
|
November 1, 1992
Intravenous-to-oral stepdown program: four years of experience in a large teaching hospital
L Frighetto, D Nickoloff, S M Martinusen, et al.
The Annals of Pharmacotherapy
|
February 17, 2000
Economic impact of standardized orders for antimicrobial prophylaxis program
L Frighetto, C A Marra, H G Stiver, et al.
CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne
|
April 1, 1993
Comparison of cefoxitin and ceftizoxime in a hospital therapeutic interchange program
S Martinusen, D Chen, L Frighetto, et al.
The Annals of Pharmacotherapy
|
April 1, 1996
Evaluation of the use of cefuroxime and cefuroxime axetil in an intravenous-oral stepdown program
S C Malfair, L Frighetto, D M Nickoloff, et al.
Neurology
|
February 26, 2004
Noninvasive linear accelerator radiosurgery as the primary treatment for trigeminal neuralgia
L Frighetto, A A De Salles, Z A Smith, et al.
Diagnostic Microbiology and Infectious Disease
|
June 23, 1998
Piperacillin/tazobactam versus imipenem: a double-blind, randomized formulary feasibility study at a major teaching hospital
F Marra, R Reynolds, G Stiver, et al.
Minimally Invasive Neurosurgery : MIN
|
March 5, 2005
Deep brain stimulation in intraoperative MRI environment - comparison of imaging techniques and electrode fixation methods
M W Y Lee, A A F De Salles, L Frighetto, et al.
Pharmacoeconomics
|
November 10, 2001
Cost-Utility analysis of tissue plasminogen activator therapy for acute ischaemic stroke: a Canadian healthcare perspective
S E Sinclair, L Frighetto, P S Loewen, et al.
Page
of 3
Search research articles
Search
Showing results (11-20 of 29) with videos related to
Sort By:
Page
of 3
Pharmacoeconomics
|
February 8, 2000
Cost-effectiveness analysis of enoxaparin versus unfractionated heparin for acute coronary syndromes. A Canadian hospital perspective
R M Balen, C A Marra, P J Zed, et al.
Pharmacoeconomics
|
January 11, 2001
Cost analysis of an adult outpatient parenteral antibiotic therapy (OPAT) programme. A Canadian teaching hospital and Ministry of Health perspective
A O Wai, L Frighetto, C A Marra, et al.
The Annals of Pharmacotherapy
|
November 1, 1992
Intravenous-to-oral stepdown program: four years of experience in a large teaching hospital
L Frighetto, D Nickoloff, S M Martinusen, et al.
The Annals of Pharmacotherapy
|
February 17, 2000
Economic impact of standardized orders for antimicrobial prophylaxis program
L Frighetto, C A Marra, H G Stiver, et al.
CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne
|
April 1, 1993
Comparison of cefoxitin and ceftizoxime in a hospital therapeutic interchange program
S Martinusen, D Chen, L Frighetto, et al.
The Annals of Pharmacotherapy
|
April 1, 1996
Evaluation of the use of cefuroxime and cefuroxime axetil in an intravenous-oral stepdown program
S C Malfair, L Frighetto, D M Nickoloff, et al.
Neurology
|
February 26, 2004
Noninvasive linear accelerator radiosurgery as the primary treatment for trigeminal neuralgia
L Frighetto, A A De Salles, Z A Smith, et al.
Diagnostic Microbiology and Infectious Disease
|
June 23, 1998
Piperacillin/tazobactam versus imipenem: a double-blind, randomized formulary feasibility study at a major teaching hospital
F Marra, R Reynolds, G Stiver, et al.
Minimally Invasive Neurosurgery : MIN
|
March 5, 2005
Deep brain stimulation in intraoperative MRI environment - comparison of imaging techniques and electrode fixation methods
M W Y Lee, A A F De Salles, L Frighetto, et al.
Pharmacoeconomics
|
November 10, 2001
Cost-Utility analysis of tissue plasminogen activator therapy for acute ischaemic stroke: a Canadian healthcare perspective
S E Sinclair, L Frighetto, P S Loewen, et al.
Page
of 3